Lingwen Ding

15PUBLICATIONS
52CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 27, 2026
Personalized Autologous Vaccines Activate Stimulator of Interferon Gene and Suppress Dendritic Cell Programmed Death Ligand 1 to Potentiate Antitumor Immunity.

|Jul 15, 2026
DNA methylation signatures distinguish extranodal NK/T-cell lymphoma and EBV-positive nodal T/NK-cell lymphoma and identify prognostic subgroups.

|Dec 15, 2025
Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin.

Manoj Garg, Deepika Kanojia, Anand Mayakonda

|Mar 04, 2024
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy.

Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun

|Nov 14, 2023
MicroRNA Landscape in Endometrial Carcinomas in an Asian population: Unraveling Subtype-Specific Signatures.

Gideon Ze Lin Tan, Sai Mun Leong, Yu Jin

|Jan 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun

Pageof 3

Frequent Collaborators

5 joint publications

H Phillip Koeffler

4 joint publications

Henry Yang

3 joint publications

Ying Li

2 joint publications

Wee Joo Chng